| Title: | Regulators of metabolic co-morbidities |
| Lead Institution: | University of Pennsylvania |
| Principal investigator: | Professor Christoph Thaiss |
Application 59657
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
About
Obesity has become highly prevalent in the human population, and obesity enhances the risk for developing a wide range of diseases, including diabetes, brain dysfunction, inflammation, and cancer. However, it is unclear what determines which obese individual will go on to develop one of these diseases and which one will not. Our study aims at identifying genetic and lifestyle factors that regulate an individual's path to health or disease. This study, which we estimate to run for three years, will enable us to develop simple tests to predict an individual's risk for developing obesity-associated diseases. It will also greatly enhance our basic understanding of the factors that work together with obesity in enhancing the disease risk in various tissues of the human body.1 Publication
| Pub ID | Title | Author(s) | Year | Journal |
|---|---|---|---|---|
| 13795 | A genome-first approach to mortality and metabolic phenotypes in MTARC1 p.Ala165Thr (rs2642438) heterozygotes and homozygotes | Carolin V Schneider (+12) | 2021 | Med |
Enabling scientific discoveries that improve human health